Halank M - Search Results

1

Halank M, Ewert R, Seyfarth HJ, Hoeffken G. Halank M, et al. J Gastroenterol. 2006 Sep;41(9):837-47. doi: 10.1007/s00535-006-1879-x. J Gastroenterol. 2006. PMID: 17048047 Review.

2

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.

Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M; STELLAR Trial Investigators. Hoeper MM, et al. N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6. N Engl J Med. 2023. PMID: 36877098 Clinical Trial.

3

[Severe precapillary pulmonary hypertension in possible antiphospholipid syndrome--partially successful long-term therapy with continuous intravenous iloprost administration. A case report with discussion of new treatment methods].

Halank M, Rubens C, Ewert R, Höffken G, Braun J. Halank M, et al. Z Rheumatol. 2000 Oct;59(5):334-42. doi: 10.1007/s003930070056. Z Rheumatol. 2000. PMID: 11142929 German.

4

Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension.

Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, Hoeffken G. Rubens C, et al. Among authors: halank m. Chest. 2001 Nov;120(5):1562-9. doi: 10.1378/chest.120.5.1562. Chest. 2001. PMID: 11713135

5

[Sildenafil in pulmonary hypertension].

Ewert R, Höper M, Halank M, Winkler J, Wensel R, Opitz C. Ewert R, et al. Among authors: halank m. Pneumologie. 2003 May;57(5):291; author reply 291-2; discussion 292. Pneumologie. 2003. PMID: 12825577 German. No abstract available.

6

Long term survival in primary pulmonary hypertension.

Halank M, Marx C, Hoeffken G. Halank M, et al. Heart. 2004 Jul;90(7):e40. doi: 10.1136/hrt.2004.035725. Heart. 2004. PMID: 15201266 Free PMC article.

7

Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension.

Halank M, Miehlke S, Hoeffken G, Schmeisser A, Schulze M, Strasser RH. Halank M, et al. Transplantation. 2004 Jun 15;77(11):1775-6. doi: 10.1097/01.tp.0000122420.86904.89. Transplantation. 2004. PMID: 15201684 No abstract available.

8

Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension.

Koehler R, Grünig E, Pauciulo MW, Hoeper MM, Olschewski H, Wilkens H, Halank M, Winkler J, Ewert R, Bremer H, Kreuscher S, Janssen B, Nichols WC. Koehler R, et al. Among authors: halank m. J Med Genet. 2004 Dec;41(12):e127. doi: 10.1136/jmg.2004.023101. J Med Genet. 2004. PMID: 15591269 Free PMC article. No abstract available.

9

Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension.

Halank M, Marx C, Miehlke S, Hoeffken G. Halank M, et al. J Gastroenterol. 2004 Dec;39(12):1222-3. doi: 10.1007/s00535-004-1478-7. J Gastroenterol. 2004. PMID: 15622492 No abstract available.

10

Bosentan therapy for portopulmonary hypertension.

Hoeper MM, Halank M, Marx C, Hoeffken G, Seyfarth HJ, Schauer J, Niedermeyer J, Winkler J. Hoeper MM, et al. Among authors: halank m. Eur Respir J. 2005 Mar;25(3):502-8. doi: 10.1183/09031936.05.00080804. Eur Respir J. 2005. PMID: 15738295 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters